
Evogene Ltd.
NASDAQ:EVGN
Overview | Financials
Company Name | Evogene Ltd. |
Symbol | EVGN |
Currency | USD |
Price | 1.43 |
Market Cap | 7,672,576 |
Dividend Yield | 0% |
52-week-range | 1.2 - 9 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ofer Haviv CPA |
Website | https://www.evogene.com |
About Evogene Ltd.
Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD